MA52121A - Traitement et prévention de pré-éclampsie - Google Patents
Traitement et prévention de pré-éclampsieInfo
- Publication number
- MA52121A MA52121A MA052121A MA52121A MA52121A MA 52121 A MA52121 A MA 52121A MA 052121 A MA052121 A MA 052121A MA 52121 A MA52121 A MA 52121A MA 52121 A MA52121 A MA 52121A
- Authority
- MA
- Morocco
- Prior art keywords
- prevention
- eclampsia
- treatment
- eclampsia treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18159064 | 2018-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52121A true MA52121A (fr) | 2021-06-02 |
Family
ID=61521416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052121A MA52121A (fr) | 2018-02-28 | 2019-02-28 | Traitement et prévention de pré-éclampsie |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20200390872A1 (fr) |
| EP (1) | EP3758739B1 (fr) |
| JP (1) | JP2021515757A (fr) |
| KR (1) | KR20210005549A (fr) |
| CN (1) | CN111818938A (fr) |
| AU (1) | AU2019226355A1 (fr) |
| BR (1) | BR112020017626A2 (fr) |
| CA (1) | CA3092163A1 (fr) |
| EA (1) | EA202092045A1 (fr) |
| IL (1) | IL276905A (fr) |
| MA (1) | MA52121A (fr) |
| MX (1) | MX2020008969A (fr) |
| PH (1) | PH12020551331A1 (fr) |
| SG (1) | SG11202008078QA (fr) |
| WO (1) | WO2019166556A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3895726A1 (fr) | 2020-04-17 | 2021-10-20 | Pharming Intellectual Property BV | Utilisation d'un inhibiteur d'estérase c1 pour traiter une détresse respiratoire aiguë liée à une infection virale |
| WO2023280981A1 (fr) | 2021-07-09 | 2023-01-12 | Pharming Intellectual Property B.V. | Utilisation d'un inhibiteur de c1 estérase pour traiter des symptômes liés à une infection virale |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992022320A1 (fr) * | 1991-06-14 | 1992-12-23 | Genentech, Inc. | Variantes de l'inhibiteur c1 et traitement des reactions inflammatoires avec l'inhibiteur c1 |
| GB9618931D0 (en) | 1996-09-11 | 1996-10-23 | Univ London | Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes |
| US7067713B2 (en) * | 2000-01-31 | 2006-06-27 | Pharming Intellectual Property B.V. | C1 Inhibitor produced in the milk of transgenic non-human mammals |
| WO2001057079A2 (fr) | 2000-01-31 | 2001-08-09 | Pharming Intellectual Property B.V. | Inhibiteur de c1 produit dans du lait de mammiferes transgeniques |
| US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
| US7544853B2 (en) * | 2003-05-16 | 2009-06-09 | Pharming Intellectual Property B.V. | C1 inhibitor with short half-life transient treatment |
| AU2006327989B2 (en) | 2005-12-21 | 2012-06-07 | Pharming Intellectual Property Bv | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury |
| CN105641688B (zh) * | 2005-12-21 | 2020-06-09 | 法明知识产权股份有限公司 | C1抑制剂在预防缺血-再灌注损伤中的应用 |
| WO2014066744A2 (fr) * | 2012-10-25 | 2014-05-01 | True North Therapeutics, Inc. | Anticorps de la c1s anti-complément et leurs utilisations |
| US20150330989A1 (en) * | 2012-11-15 | 2015-11-19 | The Brigham And Women's Hospital, Inc. | Method and system for diagnosing and treating preeclampsia |
| PL3290046T3 (pl) | 2013-03-15 | 2019-05-31 | Shire Viropharma Inc | Kompozycje c1-inh i sposoby do zapobiegania i leczenia zaburzeń związanych z niedoborem inhibitora c1 esterazy |
| WO2016081889A1 (fr) * | 2014-11-21 | 2016-05-26 | Kurt Baekgaard Osther | Inhibiteur recombinant de la c1-estérase et utilisation de celui-ci |
| MA45473A (fr) | 2016-04-04 | 2019-02-13 | Shire Human Genetic Therapies | Inhibiteur de c1 estérase conjugué et ses utilisations |
| EP3895726A1 (fr) * | 2020-04-17 | 2021-10-20 | Pharming Intellectual Property BV | Utilisation d'un inhibiteur d'estérase c1 pour traiter une détresse respiratoire aiguë liée à une infection virale |
-
2019
- 2019-02-28 CA CA3092163A patent/CA3092163A1/fr active Pending
- 2019-02-28 US US16/975,725 patent/US20200390872A1/en active Pending
- 2019-02-28 MX MX2020008969A patent/MX2020008969A/es unknown
- 2019-02-28 KR KR1020207026466A patent/KR20210005549A/ko unknown
- 2019-02-28 CN CN201980015668.4A patent/CN111818938A/zh active Pending
- 2019-02-28 BR BR112020017626-5A patent/BR112020017626A2/pt unknown
- 2019-02-28 WO PCT/EP2019/055001 patent/WO2019166556A1/fr active Application Filing
- 2019-02-28 AU AU2019226355A patent/AU2019226355A1/en active Pending
- 2019-02-28 SG SG11202008078QA patent/SG11202008078QA/en unknown
- 2019-02-28 JP JP2020545346A patent/JP2021515757A/ja active Pending
- 2019-02-28 EP EP19708487.4A patent/EP3758739B1/fr active Active
- 2019-02-28 MA MA052121A patent/MA52121A/fr unknown
- 2019-02-28 EA EA202092045A patent/EA202092045A1/ru unknown
-
2020
- 2020-08-24 IL IL276905A patent/IL276905A/en unknown
- 2020-08-26 PH PH12020551331A patent/PH12020551331A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210005549A (ko) | 2021-01-14 |
| EP3758739A1 (fr) | 2021-01-06 |
| WO2019166556A1 (fr) | 2019-09-06 |
| CN111818938A (zh) | 2020-10-23 |
| PH12020551331A1 (en) | 2021-09-06 |
| EP3758739B1 (fr) | 2024-05-15 |
| AU2019226355A1 (en) | 2020-09-17 |
| BR112020017626A2 (pt) | 2020-12-22 |
| US20200390872A1 (en) | 2020-12-17 |
| JP2021515757A (ja) | 2021-06-24 |
| SG11202008078QA (en) | 2020-09-29 |
| MX2020008969A (es) | 2021-02-16 |
| CA3092163A1 (fr) | 2019-09-06 |
| EA202092045A1 (ru) | 2020-11-09 |
| IL276905A (en) | 2020-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45192A (fr) | Traitement d'association | |
| MA50056A (fr) | Procédés de traitement de tumeur | |
| DK3743053T3 (da) | Anvendelse af cannabinoider i behandling af epilepsi | |
| MA56212A (fr) | Compositions et méthodes de traitement du cancer | |
| MA47613A (fr) | Compositions et procédés de traitement du cancer | |
| MA46061A (fr) | Traitement ascaroside de maladies auto-immunes et inflammatoires | |
| MA47820A (fr) | Traitement de la glycogénose de type iii | |
| MA52627A (fr) | Traitement du cancer | |
| MA51525A (fr) | Traitement de minéraux | |
| MA42999A (fr) | Polythérapie pour le traitement de malignités | |
| SG11202103567RA (en) | Methods of treatment of inflammatory conditions and associated infections | |
| MA42930A (fr) | Traitement de maladies neurodégénératives | |
| KR20220035425A (ko) | 자가면역 질환 치료용 조성물 및 방법 | |
| EP3428178A4 (fr) | Peptide de prévention ou de traitement de maladies inflammatoires et son utilisation | |
| IL277911A (en) | Treatment of IGE-mediated allergic diseases | |
| KR20220035457A (ko) | 치료 바이러스 백신 | |
| MA52121A (fr) | Traitement et prévention de pré-éclampsie | |
| MA53236A (fr) | Traitement des malignités des lymphocytes b | |
| GB2568986B (en) | Prevention and/or treatment of neurodegenerative disease | |
| IT201700121764A1 (it) | Composizione per il trattamento e/o la prevenzione di patologie neurodegenerative. | |
| MA54932A (fr) | Traitement contre le cancer | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| EP3428179A4 (fr) | Peptide pour la prévention ou le traitement de maladies inflammatoires et utilisation associée | |
| DE112020004659A5 (de) | Behandlungsanlage und Behandlungsverfahren | |
| DK3229811T3 (da) | Forebyggelse og behandling af betændelseslidelser |